Lili Kotmayer

MD-PhD from St jude Children’s Research Hospital, Memphis, TN. #GATA2 #IBMFS

[Dr. David J. Young, MD PhD @DrDavidJYoung]

Correlating specific variants with risk is the holy grail of IMBFS/CPS research, but findings can be so fleeting. We will succeed only with determination, careful subsetting, and examining large cohorts as occurs through collaboration as shown by @LKotmayer #ASH2024 #HemeTwitter

[Csaba Bödör @CsabaBdr1]

Great meeting with colleagues from the Gata2 ERA-PerMed consortium in Barcelona. Thanks for your time: @HeSteCBio @marrowgenes @LKotmayer @BejarOskar

[Lili Kotmayer @LKotmayer]

Our review on #GATA2 deficiency is out in the BJH! Done by the ERAPerMed GATA2 HuMo consortium led by @HeSteCBio. Proud to be a part of this! :) @CsabaBdr1 @marrowgenes https://t.co/TXsI1oatZL

[Csaba Bödör @CsabaBdr1]

#EHA2022 A great few days at EHA with my group in Vienna.

[Lili Kotmayer @LKotmayer]

Poster presentation at #EHA2022 discussing #venetoclax resistance in #CLL. Happy to be here! :) @CsabaBdr1 @BedicsGabor @bence_batai

[Csaba Bödör @CsabaBdr1]

Lili Kotmayer from our lab presenting her data on the GATA2 database generated in the framework of the GATA2HuMo consortium in Athens at the EWOG-MDS meeting. It will be online soon. Well done, Lili! @LKotmayer, @drkallay

[Csaba Bödör @CsabaBdr1]

Our paper on BTK mutations in CLL is out in BJH: Screening and monitoring of the BTKC481S mutation in a real���world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy https://t.co/Q5I6zFuXN3

[Richard Kiss MD, PhD @RichardKissMD]

Célzott terápiát támogató molekuláris onkológiai innováció a Semmelweis Egyetemen – Semmelweis Hírek https://t.co/r2wwwWAUA5

[Nagy Ákos @nagakos93]

Our lab's newest research paper is available online. Here, we demonstrate on four #follicularlymphoma patients that #liquidbiopsy based treatment monitoring with the detection of EZH2 mutations represents a real time, sensitive and radiation free approach. https://t.co/CLHjPOyCFo

[Semmelweis University @semmelweishu]

DONATE BLOOD! Save lives and contribute to uninterrupted patient care! https://t.co/ZvqAaIPks6
#COVID #COVIDー19 #COVID19 #blooddoantion #donors

[Richard Kiss MD, PhD @RichardKissMD]

Az MTA Lendület program új eredményei segíthetnek a daganatos sejtek gyógyszerekkel szembeni ellenállásának leküzdésében | MTA https://t.co/6STlTCTNVm